Published in Gene Therapy Weekly, January 19th, 2006
"Activation of the p53 network plays a central role in the inflammatory stress response associated with ulcerative colitis and may modulate cancer risk in patients afflicted with this chronic disease."
"Here," wrote F. Staib and colleagues, U.S. National Cancer Institute, "we describe the gene expression profiles associated with four microenvironmental components of the inflammatory response (NO*, H2 O2 , DNA replication arrest, and hypoxia) that result in p53 stabilization and activation."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.